Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|8|6|564-574

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.8, Iss.6, 2008-06, pp. : 564-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with aromatase inhibitors for breast cancer is associated with bone loss in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 23-26

Adis International

Access to resources Recommend Favorite

Aromatase Inhibitors in the Treatment of Postmenopausal Breast Cancer

By Bajetta E.

Drugs & Aging, Vol. 15, Iss. 4, 1999-10 ,pp. : 271-283

Adis International

Access to resources Recommend Favorite

Letrozole is an effective option in the treatment of early-stage or advanced breast cancer in postmenopausal women

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 1, 2005-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Anastrozole: A Review of its Use in Postmenopausal Women with Early-Stage Breast Cancer

By Sanford Mark Plosker Greg L.

Drugs, Vol. 68, Iss. 9, 2008-01 ,pp. : 1319-1340

Adis International

Access to resources Recommend Favorite

The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2331-2340

Blackwell Publishing

Access to resources Recommend Favorite